免疫-PET/-SPECT在CAR T细胞治疗中的当前和潜在作用
Aditi Mulgaonkar1, Durga Udayakumar1,2, Yaxing Yang1
1Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Frontiers in medicine
|July 13, 2023
概括
化学抗原受体 (CAR) T细胞疗法有前途,但面临复发和毒性挑战. 免疫学正子发射断层扫描/单光子发射计算机断层扫描 (免疫-PET/-SPECT) 成像可以通过监测CAR T细胞和指导干预来帮助克服这些障碍.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子成像分子成像技术
背景情况:
- 卡尔T细胞疗法是血液恶性瘤的突破,具有固体瘤的潜力.
- 由于抗原损失和T细胞枯竭等抵抗机制,复发率为40-60%.
- 卡尔T细胞疗法具有独特的毒性和制造/透挑战.
研究的目的:
- 审查应用免疫-PET/-SPECT成像到CAR T细胞疗法的挑战和机会.
- 探索免疫-PET/-SPECT如何解决抵抗机制和毒性.
- 评估免疫-PET/-SPECT在CAR T细胞产品开发和结果预测中的作用.
主要方法:
- 关于CAR T细胞治疗和免疫-PET/-SPECT的当前文献的综述.
- 对CAR T细胞治疗指导的分子成像策略的分析.
- 讨论CAR T细胞应用中的挑战和潜在的成像解决方案.
主要成果:
- 免疫-PET/-SPECT提供了对抗原表达的敏感,定量,非侵入性检测.
- 这些成像方法可以纵向跟踪CAR T细胞的药理动力学和疗效.
- 利用免疫-PET/-SPECT可以及时识别治疗干预的耐药性和毒性.
结论:
- 免疫-PET/-SPECT成像为指导CAR T细胞疗法提供了一个有价值的平台.
- 这种方法可以帮助克服耐药性,管理毒性,并优化CAR T细胞产品开发.
- 进一步应用免疫-PET/-SPECT具有显著的潜力,可以改善CAR T细胞治疗结果.
相关概念视频
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Imaging Studies II: Positron Emission Tomography and Scintigraphy
158
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
158
Positron Emission Tomography
4.3K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.3K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

